AMGEN INC Proceeds from Debt 2007-2026 | AMGN
Beta
What is AMGEN INC's current proceeds from debt?
AMGEN INC (AMGN) annual proceeds from debt for 2025 was $0, a NaN% decline from 2024. AMGEN INC proceeds from debt for the quarter ending March 31, 2026 was $3.96B.
What was AMGEN INC's proceeds from debt in 2024?
AMGEN INC annual proceeds from debt for 2024 was $0, a 100.00% decline from 2023.
What was AMGEN INC's proceeds from debt in 2023?
AMGEN INC annual proceeds from debt for 2023 was $27.78B, a 301.46% increase from 2022.
Proceeds from Debt History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$8.91B
→
FY2025
$0
07080910111213141516171819202122232425
5 years selected
Proceeds from Debt History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $0 | - | 10-K |
| FY2024 | $0 | -100.0% | 10-K |
| FY2023 | $27.78B | +301.5% | 10-K |
| FY2022 | $6.92B | +39.9% | 10-K |
| FY2021 | $4.95B | -44.5% | 10-K |
| FY2020 | $8.91B | - | 10-K |
| FY2019 | $0 | - | 10-K |
| FY2018 | $0 | -100.0% | 10-K |
| FY2017 | $4.48B | -38.8% | 10-K |
| FY2016 | $7.32B | +111.2% | 10-K |
| FY2015 | $3.46B | -22.6% | 10-K |
| FY2014 | $4.48B | -44.4% | 10-K |
| FY2013 | $8.05B | +63.3% | 10-K |
| FY2012 | $4.93B | -52.5% | 10-K |
| FY2011 | $10.39B | +320.4% | 10-K |
| FY2010 | $2.47B | +24.8% | 10-K |
| FY2009 | $1.98B | +99.8% | 10-K |
| FY2008 | $991.0M | -75.1% | 10-K |
| FY2007 | $3.98B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →